SPI Infoamtion

このレポートは章ごとの個別販売も行っておりますのでお問い合わせ下さい。
※全てPDFでの販売となります。

Chapter- 1: INTRODUCTION

STUDY GOALS AND OBJECTIVES
REASONS FOR DOING THE STUDY
INTENDED AUDIENCE
SCOPE OF REPORT
MARKET ANALYSES AND FORECASTS
METHODOLOGY
INFORMATION SOURCES
ANALYST CREDENTIALS
RELATED BCC REPORTS
BCC ONLINE SERVICES
DISCLAIMER

Chapter-2: SUMMARY

RESEARCH AND COMMERCIALIZATION
APPLICATIONS
DRUG DELIVERY
DRUGS AND THERAPY
IN VIVO IMAGING
IN VITRO DIAGNOSTICS
BIOMATERIALS
ACTIVE IMPLANTS
MARKET
SUMMARY TABLE NANOMEDICAL GLOBAL SALES BY THERAPEUTIC AREA, THROUGH 2014 ($ BILLIONS)
SUMMARY FIGURE NANOMEDICAL GLOBAL SALES BY THERAPEUTIC AREA, 2006-2014 ($ BILLIONS)

Chapter-3: OVERVIEW

MEDICAL NANOTECHNOLOGY: NANOMEDICINE
FUTURE POSSIBILITIES
MARKET POTENTIAL
ABOUT NANOTECHNOLOGY
THE MANY USES OF NANOTECHNOLOGY
MEDICAL APPLICATIONS
ENVIRONMENTAL APPLICATIONS
MILITARY APPLICATIONS
COSMETICS
APPLICATIONS IN DEVELOPMENT
THE TOOLS OF NANOTECHNOLOGY
C60/FULLERENES
CARBON NANOTUBES
NANOPARTICLES
NANOWIRES
MOLECULAR NANOTECHNOLOGY
RISKS OF NANOTECHNOLOGY
POISON/TOXICITY
NANOTECHNOLOGY IN THE MARKETPLACE

Chapter-4: NANOMEDICINE

DEVELOPMENT OF NANOMEDICAL TECHNOLOGIES
TABLE 1 NANOMEDICINE TIMESCALE
TABLE 2 MAIN NANOTECHNOLOGIES USED IN MEDICINE, WITH APPLICATIONS
LIPOSOMES
TABLE 3 MARKETED LIPOSOME NANOPHARMACEUTICALS
DENDRIMERS
TABLE 4 DENDRIMER PRODUCTS IN ADVANCED DEVELOPMENT
NANOCRYSTALS
TABLE 5 NANOCRYSTAL PHARMACEUTICALS
MICELLES
TABLE 6 MARKETED AND DEVELOPMENTAL PRODUCTS IN MICELLE FORM
FULLERENES
POLYMERIC NANOPARTICLES
THERAPEUTIC USES OF NANOMEDICINE
CANCER DIAGNOSTICS AND THERAPY
Silica Nanospheres
Nanoscale Hydrogel Shells
Photodynamic Therapy and Gold
Dendrimer Conjugates
Ligand-targeted Emulsion Technologies
Linear Cyclodextrin-containing Polymers
Smart Lipid-based Nanocarriers
Thermotherapy Using Magnetic Nanoparticles
Targeted Cell Destruction
Nanoshells
DRUG DELIVERY
Acusphere
AlphaRx
Aphios
Biodelivery Sciences
Bioral
Capsulution NanoScience
HealthPlus International
IGI
Labopharm
MagnaMedics
Nanocopoeia
Nanocrystal
NanoMed
Nanopharm
Nanocyte
Nanotherapeutics
Nanotrope
pSivida
SoluBest
Spherics
Telemolecular
INFECTION CONTROL
Silver Nanoparticles Against Infection
Detecting Nanobacteria
Killing Viruses
DIAGNOSTIC TOOLS
BioCrystal/InVitrogen
BioForce
Biophage
CombiMatrix
Farfield Sensors
GE Healthcare BioSciences
Immunicon
MagnaMedics
Nanogen
NanoSphere
Qiagen
Sphere
TransGenex
Veredus
VARIOUS THERAPEUTIC TARGETS AND TECHNOLOGIES
Anthrax
Cholesterol
Artificial Retina
Nerve Regeneration
Crossing the Blood-Brain Barrier
Protecting Against Radiation Damage
Antibody Therapeutics
Hemostasis
Bone Fracture Repair
Dental Implant and Tissue Regeneration
Vaccine Adjuvant
Treatment of Thrombosis
Coatings for Stents and Other Devices
FUTURE TRENDS AND RESEARCH POSSIBILITIES
Noninvasive Nanodevices
Extracellular Devices
Intracellular Devices
Nanomachines to Control Tissue Healing
Eliminating Viruses
Correcting Chemistry
New Organs and Limbs
FUNDAMENTAL NANOTECHNOLOGY RESEARCH
U.S.
University at Albany-SUNY
Cornell University
University of Michigan
Rice University
University of Pennsylvania
University of Virginia
University of North Carolina
Ohio State University
Northwestern University
University of Pittsburgh
Case Western Reserve University
University of California at Berkeley
Europe
TABLE 7 EUROPEAN NANOCENTERS
Japan
Development of Active Targeting DDS
Development of Novel Tissue Engineering
Development of New Biomaterials
THE RISK FACTOR
MARKETS FOR NANOMEDICINE
TABLE 8 MARKETED NANOPHARMACEUTICALS
TABLE 9 MARKETED NANO-IMAGING, DIAGNOSTICS, BIOMATERIALS
MARKET DRIVERS
MARKET ESTIMATES AND FORECASTS
TABLE 10 NANOTECHNOLOGY REVENUES BY INDUSTRY SECTOR, 2010 (%)
Global Nanomedicine Market
TABLE 11 GLOBAL NANOMEDICINE MARKET, THROUGH 2014 ($ BILLIONS)
Main Product Categories
Drug Delivery
Molecular Diagnostics
Market Analysis by Clinical Application
Cancer
TABLE 12 MAJOR MARKETED ANTICANCER NANOPHARMACEUTICALS, 2008 ($ BILLIONS)
TABLE 13 MARKET FORECAST FOR CANCER NANOTHERAPEUTICS AND ANODIAGNOSTICS, THROUGH 2014 ($ BILLIONS)
CNS Disorders
TABLE 14 MAJOR MARKETED CNS NANOPHARMACEUTICALS, 2008 ($ MILLIONS)
TABLE 15 MARKET FORECAST FOR CNS NANOMEDICINES, THROUGH 2014 ($ BILLIONS)
Infection
TABLE 16 MAJOR MARKETED ANTI-INFECTIVE NANOPHARMACEUTICALS, 2008 ($ BILLIONS)
TABLE 17 MARKET FORECAST FOR ANTI-INFECTION NANOTHERAPEUTICS AND NANODIAGNOSTICS, THROUGH 2014 ($ BILLIONS)
Cardiovascular and Autoimmune Disorders
TABLE 18 MAJOR MARKETED NANOMEDICINES FOR CARDIOVASCULAR AND INFLAMMATORY DISEASES, 2008 ($ MILLIONS)
TABLE 19 MARKETS FOR CARDIOVASCULAR AND ANTI-INFLAMMATORY PRODUCTS, THROUGH 2014 ($ BILLIONS)
Regional and National Market Analysis
FIGURE 1 NATIONAL SHARES OF THE GLOBAL NANOMEDICINE MARKETPLACE, 2009 (%)
U.S.
TABLE 20 U.S. NANOMEDICINE MARKET: HISTORIC AND FORECAST DATA, THROUGH 2014 ($ BILLIONS/%)
Japan
TABLE 21 NANOMEDICINE MARKET IN JAPAN: HISTORIC AND FORECAST DATA, THROUGH 2014 ($ BILLIONS/%)
Europe
TABLE 22 NANOMEDICINE MARKET IN GERMANY: HISTORIC AND FORECAST DATA, THROUGH 2014 ($ BILLIONS/%)
TABLE 23 NANOMEDICINE MARKET IN FRANCE: HISTORIC AND FORECAST DATA, THROUGH 2014 ($ BILLIONS/%)
TABLE 24 NANOMEDICINE MARKET IN UNITED KINGDOM: HISTORIC AND FORECAST DATA, THROUGH 2014 ($ BILLIONS/%)
TABLE 25 NANOMEDICINE MARKET IN ITALY: HISTORIC AND FORECAST DATA, THROUGH 2014 ($ BILLIONS/%)
TABLE 26 NANOMEDICINE MARKET IN SPAIN: HISTORIC AND FORECAST DATA, THROUGH 2014 ($ BILLION/%)

Chapter-5: COMPANY PROFILES

ABLYNX NV
ABRAXIS BIOSCIENCE
ACRYMED INC.
ACUSPHERE INC.
ADVANCED MAGNETICS
ALLTRACEL
ALPHARX INC.
ANSON NANO-BIOTECHNOLOGY
APHIOS CORP.
PROTEIN NANOPARTICLES
POLYMER NANOSPHERES
PHOSPHOLIPID NANOSOMES
BIOCRYSTAL LTD
BIOFORCE NANOSCIENCES INC.
THE VIRICHIP VIRUS DETECTION PLATFORM
BIO-GATE AG
MEDICAL APPLICATIONS
BIOPHAGE PHARMA INC.
PRODUCTS
DEVELOPMENT THROUGH COLLABORATIONS:
PHAGES
BIOPHAN TECHNOLOGIES
BIOSANTE' PHARMACEUTICALS INC.
NOVEL VACCINE ADJUVANT--BIOVANT
THERAPEUTIC DRUG DELIVERY PLATFORM―BIOAIR /BIOORAL
CALANDO PHARMACEUTICALS
C SIXTY
CAPSULUTION PHARMA AG
DRUG DELIVERY SYSTEMS
COMBIMATRIX
DRUG DEVELOPMENT
DAMAGE PREVENTION CONCEPT
ELAN DRUG TECHNOLOGIES
FARFIELD SCIENTIFIC
GE HEALTHCARE LIFE SCIENCES
HEALTHPLUS INTERNATIONAL INC.
IGI INC.
IMARX THERAPEUTICS INC.
SONOLYSIS
JR NANOTECH PLC
KEREOS, INC.
MRI AGENT FOR TUMOR DETECTION
TARGETED CHEMOTHERAPEUTICS FOR SOLID TUMORS
KI-0002 MRI AGENT FOR CARDIOVASCULAR DISEASE DETECTION
ANTI-RESTENOTIC
KEYSTONE NANO, INC.
NANOJACKETS
KLEINDIECK NANOTECHNIK
NANOWORKSTATION
LABOPHARM INC.
LIPLASOME PHARMA
LUMERA CORPORATION
NANOCAPTURE MICROARRAYS
MAGFORCE NANOTECHNOLOGIES AG
MAGNAMEDICS GMBH
MAGCUSTOM
Customized Nano- and Micro-Particles
EFFICIENT AND LOW-COST DIAGNOSTICS
MULTIFUNCTIONAL DRUG CARRIER
MICROFLUIDICS INTERNATIONAL CORPORATION
MIV THERAPEUTICS INC.
CARDIOVASCULAR HEART STENTS
MOLECULAR PROFILES
NANOBAC PHARMACEUTICALS INC
NANOBIO CORPORATION
NANOBIOTIX
NANOCARRIER CO. LTD.
NANOCOPOEIA
NANOCYTE INC
NANOGEN INC.
ELECTRONIC MICROARRAY
INSTRUMENTATION
Molecular Biology Workstation
Molecular Biology Workstation Cartridge
NanoChip 400 System
NANOINK INC.
NANOLOGIX INC.
NANOMED PHARMACEUTICALS, INC.
NANOMIX INC.
NANOPHARM AG
NANOSPECTRA BIOSCIENCES, INC.
NANOSPHERE INC.
NANOSTRUCTURES INC.
NANOSYN INC
NANOTHERAPEUTICS INC.
NANOTROPE INC.
NANOVIRICIDES INC.
FLUCIDE-I
NUCRYST PHARMACEUTICALS
WEBSITE: WWW.NUCRYST.COM
NUTRALEASE
ORION INTEGRATED BIOSCIENCES INC.
GENOMIC SIGNATURES
RATIONAL ANTIVIRAL DEVELOPMENT
DISCOVERY OF MALARIA INVASION PATHWAYS
ORTHOVITA INC
PIONEER SURGICAL TECHNOLOGY
PSIVIDA LTD
QIAGEN N.V.
SOLUBEST LTD.
SPHERICS INC.
STARPHARMA HOLDINGS LTD
DENDRIMER NANOTECHNOLOGY
TECAN GROUP LTD.
TEMOLECULAR CORPORATION
TRANSGENEX NANOBIOTECH INC.
THERAPY
APPENDIX: GLOSSARY OF TERMS
TABLE 27 GLOSSARY OF TERMS